The company behind the application, HRA Pharma, a Perrigo Company, seeks to become the first daily birth control pill available in the U.S. without a prescription.
“This historic application marks a groundbreaking moment in contraceptive access and reproductive equity in the U.S.,” said Frédérique Welgryn, Chief Strategic Operations and Innovation Officer at HRA Pharma, in a statement. “More than 60 years ago, prescription birth control pills in the U.S. empowered women to plan if and when they want to get pregnant. Moving a safe and effective prescription birth control pill to OTC will help even more women and people access contraception without facing unnecessary barriers.”
The American College of Obstetricians and Gynecologists has supported the move to make birth control available over-the-counter in its research, citing barriers to access as a reason for inconsistent or non-use of birth control pills.